Verzenio (Eli Lilly and Company)
Welcome to the PulseAid listing for the Verzenio drug offered from Eli Lilly and Company. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | abemaciclib |
| SUBSTANCE NAME: | ABEMACICLIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-09-28 |
| END MARKETING DATE: | 0000-00-00 |
Verzenio HUMAN PRESCRIPTION DRUG Details:
| Item Description | Verzenio from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2017-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-4483_8c4f9290-9ff3-459a-bd13-6a9666d5fc6a |
| PRODUCT NDC: | 0002-4483 |
| APPLICATION NUMBER: | NDA208716 |
Other ABEMACICLIB Pharmaceutical Manufacturers / Labelers:
